Related Experiment Videos
Allergy testing on the IMMULITE 2000 Random-Access immunoanalyzer - a clinical evaluation study.
Christa M Cobbaert1, Geert Jan Jonker
1Department of Clinical Chemistry, Amphia Hospital, Location Langendijk, Breda, The Netherlands. ccobbaert@amphia.nl
Clinical Chemistry and Laboratory Medicine
|October 7, 2005
Summary
The DPC IMMULITE 2000 Allergy System shows good diagnostic performance for inhalant and food allergies. This allergy testing system demonstrated acceptable sensitivity and specificity in patient diagnosis.
Area of Science:
- Allergy diagnostics
- Immunological assays
- Clinical chemistry
Background:
- Accurate diagnosis of inhalant and food allergies is crucial for patient management.
- The IMMULITE 2000 Allergy System by Diagnostic Products Corporation (DPC) offers a platform for allergy testing.
- Evaluating its diagnostic performance is essential for clinical application.
Purpose of the Study:
- To assess the diagnostic accuracy of the DPC IMMULITE 2000 Allergy System.
- Focus on detecting inhalant and food allergies through screening, mixes, and single allergens.
Main Methods:
- Serum samples from 118 new allergy patients were analyzed.
- Patients were classified as positive or negative for allergy based on clinical history and skin tests.
- Testing was conducted in a blinded manner with a positive threshold of 0.35 kU/L.
Main Results:
- The DPC inhalation screen had 82% total agreement and 91% sensitivity.
- The DPC food panel achieved 96% total agreement and 98% specificity.
- Performance varied for specific allergens, with some panels showing lower sensitivity.
Conclusions:
- The DPC IMMULITE 2000 Allergy System demonstrates generally acceptable diagnostic performance.
- The system shows good sensitivity, specificity, and total agreement compared to established diagnostic criteria.
- It is suitable for both screening and specific allergen testing in allergy diagnosis.